openPR Logo
Press release

US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 2019-2025

10-06-2020 11:34 AM CET | Health & Medicine

Press release from: Orion Market Research

The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per 100,000 population respectively in 2015. Moreover, the CDC also estimates the incidence rate of types of IBD across the country. As per the CDC, the incidence of Crohn’s disease and ulcerative colitis were nearly 14.6 and 14.3 per 100,000 population respectively in 2015. Additionally, according to the aforementioned organization, the percentage of people diagnosed with IBD (either Crohn’s disease or ulcerative colitis) increased from 0.9% of US adults in 1999 to 1.3% of US adults in 2015. This percentage is further expected to expand in the near future; thereby, promising significant growth for the IBD market during the forecast period.

A full report of US Inflammatory Bowel Disease (IBD) Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/us-ibd-inflammatory-bowel-disease-therapeutics-market

US IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. For Crohn’s and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-ibd-inflammatory-bowel-disease-therapeutics-market

The companies which are contributing to the growth of the US IBD therapeutics market include Abbott Laboratories, AbbVie Inc., Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

US Inflammatory Bowel Disease (IBD) Therapeutics Market- Segmentation

By Disease Type

• Ulcerative Colitis
• Crohn’s Disease

By Treatment Type

• Surgery
• Anti- Inflammatory Drug Administration

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-ibd-inflammatory-bowel-disease-therapeutics-market

Company Profiles

• Abbott Laboratories
• AbbVie Inc.
• Boehringer Ingelheim International GmbH
• Celgene Corp.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Laboratory Corporation of America Holdings
• Pfizer Inc.
• Sanofi S.A.
• Takeda pharmaceutical Co., Ltd.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 2019-2025 here

News-ID: 2150109 • Views: 501

More Releases from Orion Market Research

US 3D Scanning Market to Witness Growth Acceleration by 2028
The US companies contribute a significant market share in the 3D scanning market. The companies, which will share a momentous market share, are 3D Digital Corporation, 3D Systems Inc. Autodesk Inc. and so on. Additionally, more accurate and precise 3D scanners are available in the market of the US, and hence along with the high number of unit sells, it is estimated that the average cost of the scanner will
Unmanned Surface Vehicle (USV) Market Booming Worldwide with Latest Trend and Fu …
The global unmanned surface vehicle (USV) market is estimated to grow at a CAGR of nearly 14.0% during the forecast period. A significant rise in defense contracts for the development of unmanned surface vehicles is offering an opportunity for the growth of the market. The Navy has an increasing interest in USVs for maritime operations. This allows to carry out a comprehensive range of tasks, including intelligence surveillance and reconnaissance
Global Smart Indoor Garden Systems Market Worldwide Industry Analysis, Future De …
The global smart indoor garden systems market is anticipated to grow at a considerable CAGR of 8.1% during the forecast period. The smart indoor gardening system features technology that allows users to grow fresh herbs, vegetables, fruits, as well as flowers in a closed environment with high nutrition without using plant hormones, pesticides, and other harmful substances. Smart indoor gardening systems are compact and have several features such as smart
Global Online Reading Platform Market Competitive Landscape, Growth Factors, Rev …
The global online reading platform market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. One of the core factors that is fueling the market growth includes the high smartphone and tablet penetration across the globe. Over the past few years, the smartphone and tablet market witnessed exponential sales growth due to an easy excess of internet which enhanced the availability of e-books for most

All 5 Releases


More Releases for IBD

Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our
Germany IBD Therapeutics Market will experience a noticeable growth during the f …
Germany IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.4% during the forecast period. The growing IBD patient population in the region is one of the major driving forces for the growth of the market in the country. According to the national institutes of health, the prevalence of Crohn's disease in Germany was estimated to be 322 per 100,000 in Germany in 2018. Moreover, the
Canada IBD Therapeutics Market, Industry Trends, Size, Competitive Analysis and …
Canada IBD Therapeutics market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAG …
Competition is expected to remain high from 2017 to 2025 in the global inflammatory bowel disease (IBD) treatment market. During this time, the market will witness a slew of launches as manufacturers invest in the development of novel therapeutics. According to a new study by Transparency Market Research (TMR), a paradigm shift toward biosimilar and biologic drugs is expected, which will offer a fresh burst of opportunities to the global
Global Inflammatory Bowel Disease (IBD) Treatment Market to Grow at 2.6% CAGR th …
A new thorough study titled “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The global inflammatory bowel disease treatment market is projected to grow at 2.6% CAGR through 2025. In terms of revenue, the market is anticipated to reach nearly US$ 15 Bn in revenues. Request Sample Copy